The U.S. Food and Drug Administration (FDA) recently approved Palforzia, produced by Aimmune Therapeutics, to lessen allergic reactions. This includes anaphylaxis that may occur with accidental exposure to peanuts. Tyron Spearman has the story.
America’s peanut farmers, through the National Peanut Board (NPB), released the following statement supporting the significance of FDA’s approval:
“Children living with peanut allergies now have a treatment option that can profoundly change their lives. Oral Immunotherapy (OIT) is not a cure, but it has already been shown to improve the quality of life, significantly for those who completed OIT in trials.
As America’s peanut farmers, we are grateful to the researchers and families who stayed focused on this outcome because they believed a better future for allergy sufferers was both possible and important. Whether to choose OIT or continue to avoid peanuts is a personal decision and should be made in consultation with a physician or healthcare provider.”